Similar articles

• Mixed results in Q1.

  Lawrence S. Lawrence S. Nat Biotechnol. 2005 May;23(5):518. doi: 10.1038/nbt0505-518. Nat Biotechnol. 2005. PMID: 15877059 No abstract available.
• VC funding hits high in Q1.

  Lawrence S. Lawrence S. Nat Biotechnol. 2007 May;25(5):496. doi: 10.1038/nbt0507-496. Nat Biotechnol. 2007. PMID: 17483825 No abstract available.
• 2006: a stellar year for financing.

  Lawrence S. Lawrence S. Nat Biotechnol. 2007 Feb;25(2):156. doi: 10.1038/nbt0207-156. Nat Biotechnol. 2007. PMID: 17287738 No abstract available.
• The German MedTech industry in 2007.

  Schmitt JM, Beeres M. Schmitt JM, et al. Med Device Technol. 2007 Nov-Dec;18(7):56. Med Device Technol. 2007. PMID: 18075138 Review.
• Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases.

  Blair JC. Blair JC. Retina. 2005 Dec;25(8 Suppl):S105-S108. doi: 10.1097/00006982-200512001-00054. Retina. 2005. PMID: 16374312 Review. No abstract available.